1-1665970-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001290264.2(SLC35E2B):c.1030G>A(p.Val344Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,551,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290264.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35E2B | ENST00000617444.5 | c.1030G>A | p.Val344Ile | missense_variant | Exon 10 of 10 | 1 | NM_001290264.2 | ENSP00000481694.1 | ||
SLC35E2B | ENST00000614300.4 | c.732+2357G>A | intron_variant | Intron 6 of 6 | 1 | ENSP00000478733.1 | ||||
SLC35E2B | ENST00000611123.1 | c.1030G>A | p.Val344Ile | missense_variant | Exon 9 of 9 | 2 | ENSP00000484635.1 | |||
SLC35E2B | ENST00000480991.1 | n.672G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000455 AC: 7AN: 153890Hom.: 0 AF XY: 0.0000367 AC XY: 3AN XY: 81710
GnomAD4 exome AF: 0.0000650 AC: 91AN: 1399214Hom.: 0 Cov.: 31 AF XY: 0.0000710 AC XY: 49AN XY: 690122
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1030G>A (p.V344I) alteration is located in exon 9 (coding exon 8) of the SLC35E2B gene. This alteration results from a G to A substitution at nucleotide position 1030, causing the valine (V) at amino acid position 344 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at